Will there be an FDA approved medication to lower lp(a) by the end of 2027?
One-OffHealth & Medicine1JManifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-PrognoseNein 54.3%
Prognostiker
9
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 9 Stunden
Veraltet4. Jan. 26, 01:19 UTC31. Dez. 27, 23:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Will Lantern Bioworks Lumina treatment be FDA Approved for preventing tooth decay by the end of 2027?
Manifold MarketsWill there be an FDA Approved treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by 2030.
Manifold MarketsWill Lantern Bioworks Lumina treatment be FDA Approved for preventing tooth decay by the end of 2028?
Manifold MarketsOrion (a device that promises to project artificial vision into the brains of blind people) approved for sale by the end of 2027?
FutuurRaniPill microneedle pill to replace injections: approved for sale by the end of 2026?
FutuurTdi-11861 (a fast-acting male contraceptive) approved for human clinical trials by the end of 2026?
FutuurRegeln
There is currently no FDA-approved treatment for Lp(a).
- This market resolves YES if at least one medication specifically designed to lower Lp(a) receives FDA approval by December 31, 2027.
- The medication must be approved for the indication of lowering Lp(a) levels, not merely as a secondary effect of another approved drug.
- Resolution will be verified through the FDA's official approval announcements or the FDA's drug database at https://www.fda.gov/drugs/novel-drug-approvals-fda.
- Must be a medication.
- Lipoprotein apheresis does not count.
Offene Märkte
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Gesamtvolumen
- 15,6 Mio. €
- 24h-Volumen
- 18.288,2 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 5178,9 €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 weitere Ergebnisse
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Gesamtvolumen
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Gesamtvolumen
- 916.002,6 €
- 24h-Volumen
- 1515,1 €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 weitere Ergebnisse
- Gesamtvolumen
- 863.640,2 €
- 24h-Volumen
- 1039 €
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
Häufige Fragen
- Wie stehen die aktuellen Quoten für Will there be an FDA approved medication to lower lp(a) by the end of 2027??
- Manifold Markets bewertet No mit 54% (Stand: 8. September 2026).
- Wann wird Will there be an FDA approved medication to lower lp(a) by the end of 2027? entschieden?
- Will there be an FDA approved medication to lower lp(a) by the end of 2027? soll am 31. Dezember 2027 entschieden werden.
- Wie wird Will there be an FDA approved medication to lower lp(a) by the end of 2027? abgerechnet?
- Manifold Markets rechnet diesen Markt wie folgt ab: There is currently no FDA-approved treatment for Lp(a).